INRODUCTION {#sec1-1}
===========

Despite many advances in patient care, blood stream infections (BSI) remain important causes of morbidity and mortality in hospitals especially in developing countries like India. These are among top 10 leading causes of death worldwide and most significant challenges in critical care. Laboratory confirmed BSI (LCBSI) have been classified into community acquired or hospital acquired/healthcare associated; of which, the latter is of particular concern, as the patient acquires BSI during the course of receiving treatment for other conditions within a healthcare setting. Among the other healthcare associated infections, which mainly include urinary tract infections, surgical site infections, and lung infections; BSI constitute for about 14% and are one of the leading causes of death globally.\[[@ref1]\] Besides considerably affecting the mortality, LCBSI add significantly to the morbidity and economic burden of patients and hospitals. The direct and indirect costs that are affected principally include increased hospital stay, drug treatment, medical, and surgical procedures as well as patient\'s lost salary and illness.\[[@ref2]\]

Where an early diagnosis and administration of accurate antibiotics based on patient\'s blood culture report is the ideal approach of managing BSI, the empirical treatment given remains pertinent in determining patient outcome. The increasing antimicrobial resistance among pathogenic bacteria causing BSI has been reported in many studies conducted in India, and is of major concern.\[[@ref3][@ref4]\] Antimicrobial resistance is a biological phenomenon acquired by microbes in response to the selective pressure of antimicrobial agents. The cock-tail of antimicrobials, which the patient is put on, for empirically managing severely ill patients such as those having BSI, further escalates the development of drug resistance, which can be reduced if the empirical treatment is made evidence based by substantiating it with the knowledge of prevalent pathogenic organisms and their antibiograms.

Therefore, there is a dearth of observational studies, which look into local epidemiology of BSI. The lack of such updated data from central India prompted us to conduct this study, to establish the leading pathogens causing BSI in our cohort and know their antimicrobial susceptibility patterns.

MATERIALS AND METHODS {#sec1-2}
=====================

Study population {#sec2-1}
----------------

It was a prospective study conducted over a period of 13 months, starting from June 1 to June 30, 2012 in a multi-specialty sanatorium of Bhilai, Chhattisgarh, Central India. A total of 829 patients clinically suspected to have BSI, admitted in the wards of different specialties of the hospital; were included in the study.

Collection and processing of samples {#sec2-2}
------------------------------------

Venous blood, 10 ml from adults and 2-5 ml from children was obtained aseptically and inoculated into brain heart infusion broth. Blind subcultures were done on 5% sheep blood agar and MacConkey\'s agar after 24 and 48 h of incubation. A negative result was followed up by examining the broth daily and doing a final subculture at the end of the 7^th^ day or at the appearance of turbidity or gas production, which ever was earlier. Organisms were identified by cultural characters, morphology, and standard biochemical tests. Antibiotic susceptibility testing was performed by the Kirby Bauer disc diffusion method as per Central Laboratory Standards Institute (CLSI) recommendations.\[[@ref5][@ref6]\]

Interpretation of culture results {#sec2-3}
---------------------------------

Incidence of LCBSI was determined following the Centers for Disease Control and Prevention (CDC) guidelines and met one of the following criteria:

Patient had a recognized pathogen cultured from one or more blood samples,Patient had at least one of the following signs or symptoms: Fever \>38°C, chills, or hypotensionPatient \<1 year of age had at least one of the following signs or symptoms: Fever \>38°C, hypothermia \<36°C, apnea, or bradycardia.

Furthermore, those signs and symptoms and positive laboratory results were not related to an infection at another site and a commensal, when isolated --- was considered pathogenic if cultured from two or more blood samples drawn on separate occasions.\[[@ref7]\]

The patients' details, pathogen isolated, and the susceptibility patterns of all isolates were entered in excel sheets.

Patients with LCBSI were followed for the treatment given and the outcome was recorded in terms of patient discharge/mortality.

RESULTS {#sec1-3}
=======

Study population {#sec2-4}
----------------

A total of 829 subjects were enrolled in the study, out of which 438 (53%) were males. Fourteen percent (*n* = 117) of the subjects belonged to pediatric age group. From 829 patients, 846 blood samples were obtained for culture. From each suspected case of BSI, a single blood specimen was obtained initially; only in cases showing growth of coagulase negative *Staphylococcus* (CONS) (*n* = 17), a repeat blood sample was obtained to confirm pathogenicity. A total of 60 (7.2%) cases were established as LCBSI including 32 males and 28 females. The cases of LCBSI belonged to age range newborn - 88 years, with a median age of 47 years for males and 56 years for females. The underlying medical conditions of the LCBSI cases were neurological illness (17%), neurosurgical condition (12%), gastroenterological illness (10%), malignancy (10%), nephrological problem (10%), and respiratory pathology (8%). Other than this, 20% were having miscellaneous medical conditions including electrolyte imbalance, hormonal imbalance, for example, hypo-/hyperthyroidism, drowning, snake/unknown bites and diabetes mellitus; while 13% were miscellaneous pediatric cases \[[Figure 1a](#F1){ref-type="fig"}\].

![Type and distribution of bacterial pathogens causing laboratory confirmed blood stream infections (LCBSI). (a) Medical conditions for which LCBSI patients were admitted. (b, c) Frequency and distribution of pathogenic bacteria causing LCBSI. (d) Distribution of LCBSI patients in different age groups](JGID-6-141-g001){#F1}

Pathogens isolated {#sec2-5}
------------------

Of the causative pathogens, *Staphylococcus* spp. including *Staphylococcus aureus* (*n* = 13) and CONS (*n* = 7) were most prevalent (33%). Of the 17 repeat samples obtained to confirm the pathogenicity of CONS, only 7 showed the growth of the same organism on repeat blood culture, so remaining 10 were excluded as skin commensals.\[[@ref7]\] Other pathogenic bacteria were *Klebsiella pneumoniae* (20%), *Escherichia coli* (13%), *Acinetobacter* spp. (13%), *Enterococcus* spp. (12%), *Pseudomonas aeruginosa* (3%), *Proteus* spp. (2%), and *Citrobacter* spp. (2%) \[Figure [1b](#F1){ref-type="fig"} and [c](#F1){ref-type="fig"}\]. Maximum number of LCBSI cases fell in the age group of 61-80 years \[[Figure 1d](#F1){ref-type="fig"}\].

Susceptibility patterns of isolates {#sec2-6}
-----------------------------------

The susceptibility pattern of different organisms is shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. As per the CLSI guidelines, there were different set of antibiotics that were used for different organisms, and the susceptibility patterns of different pathogens were obtained.\[[@ref6]\] About 100% of isolates of the most common pathogen *Staphylococcus* spp. showed sensitivity to linezolid, teicoplanin, and vancomycin. In *Klebsiella* spp. 100% sensitivity was seen only to one antibiotic --- imipenem. In case of *E. coli* however, 100% sensitivity was not seen for any antibiotic; the highest seen was 88% sensitivity for tigecycline. Hundred percent of *P. aeruginosa* and *Acinetobacter* spp. isolates were sensitive to polymixin-B and colistin. About 100% isolates of *Enterococcus* spp. were susceptible to linezolid, teicoplanin, tigecycline, and vancomycin; whereas in *Citrobacter* spp. and *Proteus* spp. 100% isolates were found to be sensitive to tigecycline.

###### 

Antibiotic susceptibility patterns of bacterial pathogens causing LCBSI
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Outcome {#sec2-7}
-------

The patients of LCBSI were followed for treatment and outcome; overall crude mortality in LCBSI was 40% (24/60 deaths). The mortality in Gram-negative LCBSI (55%) was higher than that in Gram-positive LCBSI (22%).

DISCUSSION {#sec1-4}
==========

Blood stream infections are an important cause of morbidity and mortality in hospitalized patients. This study showed that both Gram-positive and Gram-negative bacteria were responsible for BSI, most of which were multidrug-resistant. Blood culture positivity was seen in 60/829 (7.2%) cases. In the literature, positivity in the range of 5-44% has been reported.\[[@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14]\] This wide range may be due to various reasons including:

The difference in the method of isolation and identification of organisms,The difference in the type of patients recruited for the study, as in the present study patients recruited belonged to different categories, while most of the other studies were conducted on cohort belonging to a specific category of patients such as infective endocarditis and neonatal septicemia,Difference in geographical regions, as these studies were conducted in different parts of the country andExposure of patients to a self-prescribed antibiotic, which is very common due to the availability of medicines over the counter without prescription in the country.

In our study, the incidence of Gram-positive organisms was 45%, while 55% were Gram-negative, this is in accordance with the study done by Arora *et al*. where the incidence of Gram-positive organisms was 52.67% while 47.33% isolates were Gram-negative.\[[@ref8]\] Other studies have reported a varied incidence (11.2-25%) of Gram-positive and (15-88.8%) Gram-negative organisms. The emerging higher incidence of Gram-negative organisms especially in the hospital settings is alarming.\[[@ref9][@ref10][@ref15][@ref16]\] In our study *Staphylococcus* spp. were most prevalent similar to other studies with 21.66% incidence of *S. aureus* and 11.6% of CONS.\[[@ref8][@ref9]\] In a study done by Arora *et al*. *S. aureus* was isolated in 27.37% of cases and CONS in 20.16% of the cases.\[[@ref8]\] However, Roy *et al*. have reported CONS 16.5% and *S. aureus* 14% in neonatal septicemia.\[[@ref13]\]

Among the Gram-negative bacilli 37% belonged to *Enterobacteriaceae* family including *E. coli*, *K. pneumoniae*, *Citrobacter* spp., and *Proteus* spp. One more member of the family --- *Enterobacter* spp., which is also an important nosocomial pathogen, was not observed in any of our patients; though in the literature, *Enterobacter* spp. have been reported in 14.19% and 22.9% LCBSI cases.\[[@ref8][@ref17]\] *E. coli* was isolated from 13% of the cases, at par with previous reports where 9.27% and 14.4% positivity has been reported.\[[@ref8][@ref18]\] *Citrobacter* spp. and *Proteus* spp. were very few showing only 2% positivity each, consistent with the previous findings.\[[@ref8][@ref18]\] *K. pneumoniae* was observed in 20% of the cases, which is in concert with the report by Surinder *et al*. who have reported 25.8% isolation, whereas it is high above than the report by Arora *et al*. where 5.76% positivity has been reported.\[[@ref8][@ref18]\]

Amongst other Gram-negative bacilli, *P. aeruginosa*, one of the important nil-fermenters was isolated in 5% of the cases consistent with the previous findings showing 7.62% and 5.9% positivity.\[[@ref8][@ref18]\] *Acinetobacter* spp., which is an emerging cause of late onset septicemia, was isolated in 13% of the cases, similar to study performed by Arora *et al*. showing 12.13% positivity.\[[@ref19]\] In our cohort, number of BSI positive individuals increased with age until 80 years and dropped considerably for the age group \>80 years. The reason for this observation could be a decrease in the immunity of patients with an increase in age resulting in making the individual more prone to infections, and due to recruitment of very few patients having \>80 years of age a sharp decline in BSI positivity for 80-100 years age group was observed.

The organisms isolated from the cohort of suspected cases of BSI showed resistance to various antimicrobial agents. Among Gram-positive organisms maximum resistance was shown against azithromycin, clarithromycin, erythromycin, penicillin-G (100%). Penicillin was the common antibiotic against which all Gram-positive organisms showed resistance although percent resistance was 85% in case of *Enterococcus* spp. and 100% in *Staphylococcus* spp. In other studies, high level of resistance has been reported with ampicillin and erythromycin.\[[@ref8][@ref20][@ref21]\] Most of the Gram-negative organisms showed resistance to three or more groups of antibiotics. Other workers also have reported the majority of Gram-negative isolates in their study as multidrug resistant.\[[@ref13]\] The rapid development and spread of antibiotic resistance occurs due to nonjudicial use of antibiotics.

There are studies where prevalence of BSI in specific cohorts or by specific pathogens has been looked for. The study by Prabhash *et al*. reports BSI in cancer patients, where they have found Gram-negative bacteria as more common pathogens; and have reported poor activity of primary empirical agents of BSI.\[[@ref22]\] Another study by Tak *et al*. reports *Staphylococci* as causative agents of 41% of BSI in trauma patients associated with high mortality.\[[@ref23]\]

CONCLUSION {#sec1-5}
==========

Our study thus provides information regarding prevalence and antibiotic susceptibility patterns of bacteria isolated from LCBSI. Such data is important in the selection of empirical antimicrobial treatment of BSI cases; in showing a path for clinical research and as an aid in educating and spreading awareness among medical personnel. This also draws our attention toward emerging trends of antibiotic resistance in pathogenic bacteria. However, as this was a single center study of limited duration, the results cannot be generalized for guiding empirical therapy of BSI in the area. It is highly recommended that more studies, involving patients from multiple medical centers are done to throw light on the epidemiology of infectious diseases, and the resistance patterns of common pathogens; to make practicing physicians aware of the magnitude of an existing problem of antibacterial resistance, so that they join hands in fighting this deadly threat by rational prescription of drugs.
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